THE-630

N/A

Report date: 2023/07/17 16:24:19
NME

Base Information

Drug NameTHE-630
Drug Alias NameTHE-630
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsGastrointestinal DiseasesDigestive System DiseasesGastrointestinal Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheseus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheseus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGastrointestinal DiseasesDigestive System DiseasesGastrointestinal Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksN/A